The global vacuum blood collection devices market is on a trajectory of significant growth, according to the latest projections released by FMI. The market, valued at USD 2.6 billion in 2023, is forecasted to expand at a robust compound annual growth rate (CAGR) of 6.3% throughout the forecast period, ultimately reaching USD 4.79 billion by 2033.
A growing pool of patients has led to a peak in laboratory diagnostic tests, which necessitate the use of vacuum blood collection devices for medical treatments. With blood bank centers and hospital facilities increasingly requiring modern equipment to expedite positive patient outcomes, the deployment of vacuum blood collection devices is projected to surge.
Get Sample Latest Reports: https://www.futuremarketinsights.com/reports/sample/rep-gb-5363
The demand for these devices is further bolstered by advancements in healthcare infrastructure and the rising awareness of the importance of accurate diagnostic procedures. As healthcare providers strive to enhance patient care, the adoption of efficient and reliable blood collection methods becomes paramount.
Market experts highlight that the increasing prevalence of chronic diseases and the rising number of surgical procedures are key factors driving the market’s growth. Moreover, technological innovations in blood collection devices are expected to provide further impetus to the market expansion.
Top Highlights from the FMI’s Analysis of the Vacuum Blood Collection Devices Market:
- The United States vacuum blood collection devices industry is projected to capture a market share exceeding 87.3% of North America in 2023.
- Germany is projected to clutch an 18.9% market share of the Europe vacuum blood collection devices industry.
- The China vacuum blood collection devices industry is expected to trail at a CAGR of 9.7% over the next ten years.
- The India vacuum blood collection devices industry is anticipated to register a CAGR of 8.2% in the following years.
- Over the assessment period, the serum separation tubes segment is expected to stretch at a CAGR of 6.7%.
- The plastic/PET material segment is projected to secure 84.5% of the market in 2023.
- The routine chemistry segment is estimated to multiply at a CAGR of 7.1% over the estimated period.
- Diagnostics laboratories emerged as the chief leading end user, grasping 46.6% of the overall market.
Get Customization on This Report: https://www.futuremarketinsights.com/customization-available/rep-gb-5363
Exclusive from FMI: News Reporting Competitive Scenario of the Market in Focus
- Greiner Bio-One launched MiniCollect PIXIE Heel Incision Safety Lancet in 2021. The device has been a crucial addition to the company’s product portfolio. The new safety lancet is engineered for heel incision and comes in three varieties to serve patient-centric goals.
- CSL Plasma and Terumo Blood and Cell Technologies together announced their collaboration in 2021. As a result of this collaboration, the companies aim to provide a novel plasma collection platform.
- Quest Diagnostics Incorporated obtained Nationwide Laboratory Services, based in Boca Raton, in 2021. This new development is expected to widen the prospects of gaining insights and grabbing diagnostic innovation. An increase in healthcare accessibility is projected to empower South Florida’s communities with improved medical health.
Key Companies Profiled:
- Becton, Dickinson, & Company
- Greiner Bio-One GmbH
- Guangzhou Improve Medical Instruments Co., Ltd
- AB Medical, Inc.
- SARSTEDT AG & Co. KG
- Cardinal Health
- Poly Medicure Ltd.
- FL Medical
- InterVac Technology
- Chengdu Rich Science Industry Co., Ltd.,
- Zhejiang Gongdong Medical Technology Co. Ltd.
- Aptaca Spa.
- Hindustan Syringes & Medical Devices
- DJO Global Inc.
- BTL
- Spectro Analytic Irradia AB
- Photomedex
- others
A Full Report on Market: https://www.futuremarketinsights.com/checkout/5363
Vacuum Blood Collection Devices by Category:
By Product:
- Serum Separation Tubes
- Serum Clot Activators/Serum Gel + Clot Activator
- Silica
- Thrombin
- Plasma Analysis/Anti-coagulants
- EDTA Tubes
- Lithium Heparin
- Sodium Heparin
- Coagulation Analysis Tubes
- Glucose Analysis Tubes
- Sodium Fluoride
- Potassium Fluoride
- Fluoride Oxide
- Others
By Material:
- PET/Plastic
- Glass
By Application:
- Serology & Immunology
- Routine Chemistry
- Blood Typing
- Molecular Genetics
- Blood Sugar Assay
- Others
By End User:
- Diagnostic Centers
- Hospitals & Clinics
- Research & Academic Institutes
- Veterinary Hospitals & Clinics
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- The Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
